Insurance companies are hurting from the high cost of hepatitis C drug Sovaldi. Arthur Caplan, NYU Langone Medical Center, and CNBC's Bertha Coombs, share their opinions.» Read More
Drug pricing pressure under a Democratic administration be darned. $75,000. That's not a salary figure. That's the price one biotech analyst says Vertex Pharmaceuticals and its partner Johnson & Johnson might be able to charge--possibly even more--for their Hepatitis C drug.
Insurance used to be a given. When a team signed a big guaranteed contract, they'd get it insured as much as they could. But times have changed. Last month, I was told that more and more baseball teams were passing up on insurance.
The best move you can make when and if you're let go may not be intuitive: geting and maintaining health insurance.
Flight insurance is a joke. Never buy it. Instead, spend your money where it can really protect your trip.
Losing your job should not mean losing your healthcare. Period.
The inside scoop on key moves you need to make should you find yourself on the company chopping block.
Lost your job? You're not alone. Here are the four ways to stay afloat in this awful market.
Market got you down? The situation might not be as bad as you think.
With gas cheaper, mortgage rates coming down and a winter of cheaper heating bills to possibly look forward to, there might be reason for some holiday cheer.
Hartford is seeing heavy options trading Friday, as its stock soars more than 88% even as the broader markets drop. Hartford Financial Services, which has an average daily call volume of 10,000 contracts, saw 37,100 calls trade in the first hour of trading this morning. That's three times full session volume in just 60 minutes!
That's what this first-of-a-kind product from UnitedHealth purports to do. But do you need it?
Earlier this week UBS pharmaceutical analyst Roopesh Patel put out a big 2009 sector outlook research note claiming, "So far, the global economic slowdown has had no noticeable impact — a) U.S. weekly and monthly U.S. prescription trends are stable; b) there also is no meaningfully cautionary commentary from any of the companies...." Well, he might have spoken too soon.
The Insurance Institute for Highway Safety designated 72 vehicles as winners of their top safety pick award. The award recognizes vehicles that do the best job of protecting motorists in front, side and rear crashes and have anti-rollover technology called Electronic Stability Control, or ESC.
In a special edition 'Outrage of the Day,' Cramer has not one, but two gripes on his mind: one personal and one business, which is the one he decides to start with, since "we're not about making friends on this show, we're about making money."
How do US tax payers feel about supporting the liquidity of Dutch insurer Aegon?
Citirgoup announces it will significantly cut down its workforce, while pirates who hijacked a crude oil tanker off the coast of Kenya approach a Somali port. Following are today's top videos:
Cramer makes room in the Sell Block today for a whole gang of misfits, based on analysis that Goldman Sachs released on Tuesday. Today's Sell Block detainees: life insurance companies like Lincoln, Hartford, Prudential and Principal. To put it simply, they're in "big trouble," according to Goldman's piece.
Big pharma's got big problems. That should not come as news to anyone who works for, follows or invests in the industry.
It sounds simple enough, but this sector's at the heart of all our problems, Cramer says.
This stock's performance is a key barometer for the market, Cramer says.
Get the best of CNBC in your inbox